Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Young, John D ^a,b,c   Martel, Jan ^a   Young, David ^a,d   Young, Andrew ^a   Hung, Chin Ming ^a   Young, Lena ^a,e   Chao, Ying Jie ^a   Young, James ^a   Wu, Cheng Yeu ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b ROCKEFELLER UNIVERSITY   (United States)

^c MING CHI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APATITE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CALCIUM; CALCIUM PHOSPHATE; COMPLEMENT COMPONENT C3; FETUIN A; HYDROXYAPATITE; NANOPARTICLE; MULTIPROTEIN COMPLEX; NANOMATERIAL; PLASMA PROTEIN;

ARTICLE; BACTERIAL GROWTH; BINDING SITE; BIOMINERALIZATION; CELL CULTURE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CULTURE MEDIUM; GROWTH INHIBITION; HOMEOSTASIS; NANOBACTERIA; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN POLYMORPHISM; PROTEOBACTERIA; SPINDLE CELL; ANIMAL; BACTERIUM; BLOOD; CATTLE; CHEMISTRY; HUMAN; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NANOTECHNOLOGY; POWDER DIFFRACTION; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

BOVINAE;

ANIMALS; APATITES; BACTERIA; BLOOD PROTEINS; CALCIUM; CATTLE; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MULTIPROTEIN COMPLEXES; NANOSTRUCTURES; NANOTECHNOLOGY; POWDER DIFFRACTION; PRECIPITATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN;

EID: 65549108236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005421     Document Type: Article

References (157)

1. Kajander EO, Kuronen I, Åkerman K, Pelttari A, Çiftçioglu N (1997) Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth. Proc Soc Photo Opt Instrum Eng 3111: 420-428.
2. Kajander EO, Çiftçioglu N (1998) Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 95: 8274-8279.
3. Kajander EO (2006) Nanobacteria: propagating calcifying nanoparticles. Lett Appl Microbiol 42: 549-552.
4. Ciftcioglu N, McKay DS, Mathew G, Kajander EO (2006) Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. J Investig Med 54: 385-394.
5. Çiftçioglu N, Björklund M, Kuorikoski K, Bergström K, Kajander EO (1999) Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56: 1893-1898.
6. Kajander EO, Ciftcioglu N, Aho K, Garcia-Cuerpo E (2003) Characteristics of nanobacteria and their possible role in stone formation. Urol Res 31: 47-54.
7. Ciftcioglu N, Aho KM, McKay DS, Kajander EO (2007) Are apatite nanoparticles safe? Lancet 369: 2078.
8. Lieske JC (2008) Can biologic nanoparticles initiate nephrolithiasis? Nature Clin Pract Nephrol 4: 308-309.
9. Folk RL (1993) SEM imaging of bacteria and nannobacteria in carbonate sediments and rocks. J Sediment Petrol 63: 990-999.
10. Sillitoe RH, Folk RL, Sarie N (1996) Bacteria as mediators of copper sulfide enrichment during weathering. Science 272: 1153-1155.
11. McKay DS, Gibson EK Jr, Thomas-Keprta KL, Vali H, Romanek CS, et al. (1996) Search for past life on Mars: Possible relic biogenic activity in Martian meteorite ALH84001. Science 273: 924-930.
12. Urbano P, Urbano F (2007) Nanobacteria: facts or fancies? PLoS Pathog 3: e55.
13. Young JD, Martel J, Young L, Wu C-Y, Young A, et al. (2009) Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS ONE 4: e4417.
14. Cisar JO, Xu DQ, Thompson J, Swain W, Hu S, et al. (2000) Alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A 10: 11511-11515.
15. Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, et al. (2008) Nanobacteria are mineralo fetuin complexes. PLoS Pathog 4: e41.
16. Martel J, Young JD (2008) Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci U S A 105: 5549-5554.
17. Vali H, McKee MD, Çiftçioglu N, Sears SK, Plows FL, et al. (2001) Nanoforms: a new type of protein-associated mineralization. Geochim Cosmochim Acta 65: 63-74.
18. Benzerara K, Miller VM, Barell G, Kumar V, Miot J, et al. (2006) Search for microbial signatures within human and microbial calcifications using soft X-ray spectromicroscopy. J Invest Med 54: 367-379.
19. Kirkland BL, Lynch FL, Rahnis MA, Folk RL, Molineux IJ, et al. (1999) Alternative origins for nannobacteria-like objects in calcite. Geology 27: 347-350.
20. Benzerara K, Menguy N, Guyot F, Dominici C, Gillet P (2003) Nanobacterialike calcite single crystals at the surface of the Tataouine meteorite. Proc Natl Acad Sci U S A 100: 7438-7442.
21. García-Ruiz JM, Hyde ST, Carnerup AM, Christy AG, Van Kranendonk MJ, et al. (2003) Self-assembled silica-carbonate structures and detection of ancient microfossils. Science 302: 1194-1197.
22. García-Ruiz JM, Melero-García E, Hyde ST (2009) Morphogenesis of self-assembled nanocrystalline materials of barium carbonate and silica. Science 323: 362-365.
23. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, et al. (2000) Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 57: 2360-2374.
24. Kumar V, Farell G, Yu S, Harrington S, Fitzpatrick L, et al. (2006) Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Investig Med 54: 412-424.
25. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, et al. (2004) Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287: 1115-1124.
26. Bratos-Pérez MA, Sánchez PL, García de Cruz S, Villacorta E, Palacios IF, et al. (2008) Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification. Eur Heart J 29: 371-376.
27. Schwartz MA, Lieske JC, Kumar V, Farell-Baril G, Miller VM (2008) Human-derived nanoparticles and vascular response to injury in rabbit carotid arteries: proof of principle. Int J Nanomedicine 3: 243-248.
28. Ç,iftçioǧlu N, Vejdani K, Lee O, Mathew G, Aho KM, et al. (2008) Association between Randall's plaque and calcifying nanoparticles. Int J Nanomedicine 3: 105-115.
29. Ryall RL (2008) The future of stone research: rummagings in the attic, Randall's plaque, nanobacteria, and lessons from phylogeny. Urol Res 36: 77-97.
30. Heiss A, Eckert T, Aretz A, Richtering W, van Dorp W, et al. (2008) Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J Biol Chem 283: 14815-14825.
31. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM (2008) Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 73: 384-390.
32. Westenfeld R, Jahnen-Dechent W, Ketteler M (2007) Vascular calcification and fetuin-A deficiency in chronic kidney disease. Trends Cardiovasc Med 17: 124-128.
33. Ketteler M, Westenfeld R, Schlieper G, Brandenburg V, Floege J (2005) "Missing" inhibitors of calcification: general aspects and implications in renal failure. Pediatr Nephrol 20: 383-388.
34. Ketteler M, Brandenburg V, Jahnen-Dechent W, Westenfeld R, Floege J (2005) Do not be misguided by guidelines: the calciumxphosphate product can be a Trojan horse. Nephrol Dial Transplant 20: 673-677.
35. Jahnen-Dechent W, Schäfer C, Heiss A, Grötzinger J (2001) Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin. Z Kardiol 90: 47-56.
36. Çíftçíoglu N, Miller-Hjelle MA, Hjelle JT, Kajander EO (2002) Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 46: 2077-2086.
37. Wiesmann HP, Nazer N, Klatt C, Szuwart T, Meyer U (2003) Bone tissue engineering by primary osteoblast-like cells in a monolayer system and 3-dimensional collagen gel. J Oral Maxillofac Surg 61: 1455-1462.
38. Hatori M, Oomamiuda K, Kokubun S (1996) Hydroxyapatite crystals in tumoral calcinosis: a case report. Tohoku J Exp Med 180: 359-364.
39. Lee YS (1993) Morphogenesis of calcification in porcine bioprosthesis: insight from high resolution electron microscopic investigation at molecular and atomic resolution. J Electron Microsc (Tokyo) 42: 156-165.
40. Heiss A, DuChesne A, Denecke B, Grötzinger J, Yamamoto K, et al. (2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. J Biol Chem 278: 13333-13341.
41. Heiss A, Jahnen-Dechent W, Endo H, Schwahn D (2007) Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids. Biointerphases 2: 16-20.
42. Boskey AL, Vigorita VJ, Sencer O, Stuchin SA, Lane JM (1983) Chemical, microscopic, and ultrastructural characterization of the mineral deposits in tumoral calcinosis. Clin Orthop Relat Res 178: 258-269.
43. Ruiz FA, Lea CR, Oldfield E, Docampo R (2004) Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem 279: 44250-44257.
44. Kokubun S, Ozawa H, Sakurai M, Tanaka Y (1996) Tumoral calcinosis in the upper cervical spine: a case report. Spine 21: 249-252.
45. Carden A, Morris MD (2000) Application of vibrational spectroscopy to the study of mineralized tissues (review). J Biomed Opt 5: 259-268.
46. Barrère F, van Blitterswijk CA, de Groot K (2006) Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomed 1: 317-332.
47. Aizenberg J, Lambert G, Addadi L, Weiner S (1996) Stabilization of amorphous calcium carbonate by specialized macromolecules in biological and synthetic precipitates. Adv Mater 8: 222-226.
48. Raz S, Testeniere O, Hecker A, Weiner S, Luquet G (2002) Stable amorphous calcium carbonate is the main component of the calcium storage structures of the crustacean Orchestia cavimana. Biol Bull 203: 269-274.
49. Barralet J, Best S, Bonfield W (1998) Carbonate substitution in precipitated hydroxyapatite: an investigation into the effects of reaction temperature and bicarbonate ion concentration. J Biomed Mater Res Part A 41: 79-86.
50. Vallet-Regí M, Rámila A (2000) New bioactive glass and changes in porosity during the growth of a carbonate hydroxyapatite layer on glass surfaces. Chem Mater 12: 961-965.
51. Ayman A, Talaat MS, Negm S, Talaat H (2008) Investigation of biophysical characteristics of diabetic living eye tissues using PA-FTIR-spectroscopy. Eur Phys J Spec Top 153: 497-501.
52. Chen CW, Oakes CS, Byrappa K, Riman RE, Brown K, et al. (2004) Synthesis, characterization, and dispersion properties of hydroxyapatite prepared by mechanochemical-hydrothermal methods. J Mater Chem 14: 2425-2432.
53. Singh S, Bhardwaj P, Singh V, Aggarwal S, Mandal UK (2008) Synthesis of nanocrystalline calcium phosphate in microemulsion-effect of nature of surfactants. J Colloid Interface Sci 319: 322-329.
54. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, et al. (2003) Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607-616.
55. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, et al. (2007) Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken) 290: 1315-1323.
56. Narasimhulu KV, Gopal NO, Lakshmana Rao J, Vijayalakshmi N, Natarajan S, et al. (2004) Structural studies of the biomineralized species of calcified pancreatic stones in patients suffering from chronic pancreatitis. Biophys Chem 114: 137-147.
57. de Mul FF, Hottenhuis MH, Bouter P, Greve J, Arends J, et al. (1986) Micro-Raman line broadening in synthetic carbonated hydroxyapatite. J Dent Res 65: 437-440.
58. Penel G, Leroy G, Rey C, Bres E (1998) MicroRaman spectral study of the PO4 and CO3 vibrational modes in synthetic and biological apatites. Calcif Tissue Int 63: 475-481.
59. Kale S, Biermann S, Edwards C, Tarnowski C, Morris M, et al. (2000) Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol 18: 954-958.
60. Addadi L, Raz S, Weiner S (2003) Taking advantage of disorder: amorphous calcium carbonate and its roles in biomineralization. Adv Mat 15: 959-970.
61. Frost RL, Cejka J, Ayoko GA, Weier M (2007) A Raman spectroscopic study of the uranyl phosphate mineral bergenite. Spectrochim Acta A Mol Biomol Spectrosc 66: 979-984.
62. Walton AG, Deveney MJ, Koenig JL (1970) Raman spectroscopy of calcified tissue. Calcif Tissue Res 6: 162-167.
63. de Paula AR, Sathaiah S (2005) Raman spectroscopy for diagnosis of atherosclerosis: a rapid analysis using neural networks. Med Eng Phys 27: 237-244.
64. Plate U, Arnold S, Reimer L, Höhling H-J, Boyde A (1994) Investigation of the early mineralisation on collagen in dentine of rat incisors by quantitative electron spectroscopic diffraction (ESD). Cell Tissue Res 278: 543-547.
65. Potter K, Leapman RD, Basser PJ, Landis WJ (2002) Cartilage calcification studied by proton nuclear magnetic resonance microscopy. J Bone Miner Res 17: 652-660.
66. Cantet S, Fanjul M, Brémont F, Midy V, Hollande E (2001) Cytological characterization of apatitic calcium phosphate structures in bronchial epithelial tissue cultured from a child with cystic fibrosis (deltaF508). Virchows Arch 439: 683-690.
67. Olszta MJ, Cheng X, Jee SS, Kumar R, Kim Y-Y, et al. (2007) Bone structure and formation: A new perspective. Mat Sci Eng 58: 77-116.
68. Jahnen-Dechent W, Schäfer C, Ketteler M, McKee MD (2008) Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 86: 379-389.
69. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, et al. (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4: 1265-1272.
70. Zhou HY (2007) Proteomic analysis of hydroxyapatite interaction proteins in bone. Ann N Y Acad Sci 1116: 323-326.
71. Ashton BA, Triffitt JT, Herring GM (1974) Isolation and partial characterization of a glycoprotein from bovine cortical bone. Eur J Biochem 45: 525-533.
72. Ohnishi T, Arakaki N, Nakamura O, Hirono S, Daikuhara Y (1991) Purification, characterization, and studies on biosynthesis of a 59-kDa bone sialic acid-containing protein (BSP) from rat mandible using a monoclonal antibody. Evidence that 59-kDa BSP may be the rat counterpart of human alpha 2-HS glycoprotein and is synthesized by both hepatocytes and osteoblasts. J Biol Chem 266: 14636-14645.
73. Quelch KJ, Cole WG, Melick RA (1984) Noncollagenous proteins in normal and pathological human bone. Calcif Tissue Int 36: 545-549.
74. Brown WM, Saunders NR, Møllgård K, Dziegielewska KM (1992) Fetuin - an old friend revisited. Bioessays 14: 749-755.
75. Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, et al. (2006) Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 52: 227-234.
76. Wong F (2007) Drug insight: the role of albumin in the management of chronic liver disease. Nature Clin Pract Gastroenterol Hepatol 4: 43-51.
77. Johansson L, Klinth J, Holmqvist O, Ohlson S (2003) Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotech 42: 67-74.
78. Olson RE (1998) Discovery of the lipoproteins, their role in fat transport and their significance as risk factors. J Nutr 128 (Suppl 2): 439-443.
79. Boskey AL (1998) Biomineralization: conflicts, challenges, and opportunities. J Cell Biochem 30-31 (Suppl): 83-91.
80. Garnett J, Dieppe P (1990) The effects of serum and human albumin on calcium hydroxyapatite crystal growth. Biochem J 266: 863-868.
81. Terkeltaub RA, Santoro DA, Mandel G, Mandel N (1988) Serum and plasma inhibit neutrophil stimulation by hydroxyapatite crystals. Evidence that serum alpha 2-HS glycoprotein is a potent and specific crystal-bound inhibitor. Arthr Rheum 31: 1081-1089.
82. Blumenthal NC (1989) Mechanisms of inhibition of calcification. Clin Orthop Relat Res 247: 279-289.
83. Jahnen-Dechent W (2004) Lot's wife's problem revisited: how we prevent pathological calcification. In Baeuerlein E, ed. Biomineralization. Progress in biology, molecular biology and application. Weinheim: Wiley-VCH. pp 243-267.
84. Meyer JL (1984) Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231: 1-8.
85. Fleisch H, Russell RG (1972) A review of the physiological and pharmacological effects of pyrophosphate and diphosphonates on bones and teeth. J Dent Res 51: 324-332.
86. Russell RG, Rogers MJ, Frith JC, Luckman SP, Coxon FP, et al. (1999) The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res 14 (Suppl 2): 53-65.
87. Doherty TM, Asotra K, Fitzpatrick LA, Qiao JH, Wilkin DJ, et al. (2003) Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 100: 11201-11206.
88. Goodman WG (2002) Vascular calcification in end-stage renal disease. J Nephrol 15 (Suppl 6): 82-85.
89. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, et al. (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740.
90. Benesch J, Mano JF, Reis RL (2008) Proteins and their peptide motifs in acellular apatite mineralization of scaffolds for tissue engineering. Tissue Eng Part B Rev 14: 433-445.
91. Schinke T, Amendt C, Trindl A, Pöschke O, Müller-Esterl W, et al. (1996) The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. J Biol Chem 271: 20789-20796.
92. Rochette CN, Rosenfeldt S, Heiss A, Narayanan T, Ballauff M, et al. (2009) A shielding topology stabilizes the early stage protein-mineral complexes of fetuin-A and calcium phosphate: a time-resolved small-angle X-ray study. Chembiochem 10: 735-740.
93. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, et al. (2002) Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronatetreated rats. J Biol Chem 277: 3926-3934.
94. Price PA, Nguyen TMT, Williamson MK (2003) Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 278: 22153-22160.
95. Price PA, Lim JE (2003) The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem 278: 22144-22152.
96. Price PA, Williamson MK, Nguyen TM, Than TN (2004) Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279: 1594-1600.
97. Price PA, June HH, Hamlin NJ, Williamson MK (2004) Evidence for a serum factor that initiates the re-calcification of demineralized bone. J Biol Chem 279: 19169-19180.
98. Price PA, Chan WS, Jolson DM, Williamson MK (2006) The elastic lamellae of devitalized arteries calcify when incubated in serum: evidence for a serum calcification factor. Arterioscler Thromb Vasc Biol 26: 1079-1085.
99. Price PA, Toroian D, Chan WS (2009) Tissue-nonspecific alkaline phosphatase is required for the calcification of collagen in serum: A possible mechanism for biomineralization. J Biol Chem 284: 4594-4604.
100. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, et al. (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361: 827-833.
101. Wang AY, Woo J, Lam CW, Wang M, Chan IH, et al. (2005) Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20: 1676-1685.
102. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, et al. (2005) Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67: 2383-2392.
103. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, et al. (2007) Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the heart and soul study. Circulation 115: 2533-2539.
104. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, et al. (1979) Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64: 1118-1129.
105. Daveau M, Christian-Davrinche, Julen N, Hiron M, Arnaud P, et al. (1988) The synthesis of human alpha-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells. FEBS Lett 241: 191-194.
106. Lewis JG, André CM (1980) Effect of human alpha 2 HS glycoprotein on mouse macrophage function. Immunology 39: 317-322.
107. Thiele L, Diederichs JE, Reszka R, Merkle HP, Walter E (2003) Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells. Biomaterials 24: 1409-1418.
108. Jersmann HP, Dransfield I, Hart SP (2003) Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci (Lond) 105: 273-278.
109. Aoki H, Aoki H (1996) Acute toxicity of hydroxyapatite microcrystal suspension by intraveneous injection in rats. In: Transactions of the annual meeting of the society for biomaterials in conjugation with the international materials. St-Louis Park: Society for Biomaterials. 357 p.
110. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311: 622-627.
111. Robinson C, Fuchs P, Weatherell JA (1981) The appearance of developing rat incisor enamel using a freeze fracturing technique. J Cryst Growth 53: 160-165.
112. Bonucci E (2002) Crystal ghosts and biological mineralization: fancy specters in an old castle, or neglected structures worthy of belief? J Bone Miner Metab 20: 249-265.
113. Gupta HS, Seto J, Wagermaier W, Zaslansky P, Boesecke P, et al. (2006) Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc Natl Acad Sci U S A 103: 17741-17746.
114. Robinson C (2007) Self-oriented assembly of nano-apatite particles: a subunit mechanism for building biological mineral crystals. J Dent Res 86: 677-679.
115. Cölfen H, Antonietti M (2005) Mesocrystals: inorganic superstructures made by highly parallel crystallization and controlled alignment. Angew Chem Int Ed Engl 44: 5576-5591.
116. Zhou L, O'Brien P (2008) Mesocrystals: a new class of solid materials. Small 4: 1566-1574.
117. Ziegler A, Fabritius H, Hagedorn M (2005) Microscopical and functional aspects of calcium-transport and deposition in terrestrial isopods. Micron 36: 137-153.
118. Vandenbulcke F, Grelle C, Fabre MC, Descamps M (1998) Implication of the midgut of the centipede Lithobius forficatus in the heavy metal detoxification process. Ecotoxicol Environ Safety 41: 258-268.
119. Pigino G, Migliorini M, Paccagnini E, Bernini F, Leonzio C (2005) Fine structure of the midgut and Malpighian papillae in Campodea (Monocampa) quilisi Silvestri, 1932 (Hexapoda, Diplura) with special reference to the metal composition and physiological significance of midgut intracellular electrondense granules. Tissue Cell 37: 223-232.
120. Docampo R, de Souza W, Miranda K, Rohloff P, Moreno SN (2005) Acidocalcisomes - conserved from bacteria to man. Nat Rev Microbiol 3: 251-261.
121. Samoylov AM, Samoylova TI, Pustovyy OM, Samoylov AA, Toivio-Kinnucan MA, et al. (2005) Novel metal clusters isolated from blood are lethal to cancer cells. Cells Tissues Organs 179: 115-124.
122. Evan A, Lingeman J, Coe FL, Worcester E (2006) Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69: 1313-1318.
123. Coe FL, Evan A, Worcester E (2005) Kidney stone disease. J Clin Invest 115: 2598-2608.
124. Ghadially FN (2001) As you like it, part 3: a critique and historical review of calcification as seen with the electron microscope. Ultrastruct Pathol 25: 243-267.
125. Harasawa R, Tanabe H, Kurematsu M, Mizusawa H, Suzuki Y (2006) Self-propagating calciferous particles detected in a human cell line Kasumi-6 (JCRB1024). In Vitro Cell Dev Biol Anim 42: 13-15.
126. Anderson L, McDonald JR (1946) The origin, frequency, and significance of microscopic calculi in the kidney. Surg Gynecol Obstet 82: 275-282.
127. Carr RJ (1954) A new theory on the formation of renal calculi. Br J Urol 26: 105-117.
128. Haggitt RC, Pitcock JA (1971) Renal medullary calcifications: a light and electron microscopic study. J Urol 106: 342-347.
129. Khan SR, Finlayson B, Hackett R (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urology 23: 194-199.
130. Travis J (1998) The bacteria in the stone: extra-tiny microorganisms may lead to kidney stones and other diseases. Science News 154: 75-77.
131. Carson DA (1998) An infectious origin of extraskeletal calcification. Proc Natl Acad Sci U S A 95: 7846-7847.
132. Bradbury J (1998) Nanobacteria may lie at the heart of kidney stones. Lancet 352: 121.
133. Day M (1998) Mean microbes - hard little bugs could cause everything from tumours to dementia. New Scientist 159: 11.
134. Abbott A (1999) Battle lines drawn between 'nanobacteria' researchers. Nature 401: 105.
135. Dorrell S (1999) Nanobacteria linked to kidney disease. Mol Med Today 5: 373.
136. Abbott A (2000) Researchers fail to find signs of life in 'living' particles. Nature 408: 394.
137. Travis J (2000) Study casts doubt on minibacteria. Science News 158: 328.
138. Hamilton A (2000) Nanobacteria: gold mine or minefield of intellectual enquiry? Microbiol Today 27: 182-184.
139. Hogan J (2003) 'Microfossils' made in the laboratory. New Scientist 2422: 14-15.
140. Hopkins M (2008) Nanobacteria theory takes a hit. nature.com. Available: .
141. Deresinski S (2008) Nan(non)bacteria. Clin Inf Dis 47: v-vi.
142. Saey TH (2008) Rest in peace nanobacteria, you were not alive after all. Science News 173: 6.
143. Shiekh FA, Miller VM, Lieske JC (2009) Do calcifying nanoparticles promote nephrolithiasis? A review of the evidence. Clin Nephrol 71: 1-8.
144. Anderson HC, Garimella R, Tague SE (2005) The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 10: 822-837.
145. Genge BR, Wu LN, Wuthier RE (1990) Differential fractionation of matrix vesicle proteins. Further characterization of the acidic phospholipid-dependent Ca2(+)-binding proteins. J Biol Chem 265: 4703-4710.
146. Ali SY, Sajdera SW, Anderson HC (1970) Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. Proc Natl Acad Sci U S A 67: 1513-1520.
147. Matsuzawa T, Anderson HC (1971) Phosphatases of epiphyseal cartilage studied by electron microscopic cytochemical methods. J Histochem Cytochem 19: 801-808.
148. Genge BR, Wu LN, Wuthier RE (2007) In vitro modeling of matrix vesicle nucleation: synergistic stimulation of mineral formation by annexin A5 and phosphatidylserine. J Biol Chem 282: 26035-26045.
149. Wuthier RE, Wians FH Jr, Giancola MS, Dragic SS (1978) In vitro biosynthesis of phospholipids by chondrocytes and matrix vesicles of epiphyseal cartilage. Biochemistry 17: 1431-1436.
150. Hirschman A, Deutsch D, Hirschman M, Bab IA, Sela J, et al. (1983) Neutral peptidase activities in matrix vesicles from bovine fetal alveolar bone and dog osteosarcoma. Calcif Tissue Int 35: 791-797.
151. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, et al. (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867.
152. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, et al. (2005) Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16: 2920-2930.
153. Hugel B, Martínez MC, Kunzelmann C, Freyssinet JM (2004) Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20: 22-27.
154. Chin W-C, Orellana MV, Verdugo P (1998) Spontaneous assembly of marine dissolved organic matter into polymer gels. Nature 391: 568-572.
155. Wainwright M (1999) Nanobacteria and associated 'elementary bodies' in human disease and cancer. Microbiology 145: 2623-2624.
156. Domingue GJ, Woody HB (1997) Bacterial persistence and expression of disease. Clin Microbiol Rev 10: 320-344.
157. Çiftçioglu N, Kajander EO (1998) Interaction of nanobacteria with cultured mammalian cells. Pathophysiol 4: 259-270.